NEW YORK, NY., July 27, 2023 (GenomeWeb) -- Molecular diagnostics startup Circular Genomics has identified a new biomarker that can predict which patients are likely to respond to Pfizer's antidepressant Zoloft (Sertraline).
Circular Genomics Readying to Launch Zoloft Response Diagnostic Based on Circular RNA Biomarker
Updated: Jul 23, 2024
コメント